Study of Levofloxacin and Cefoperazone-Sulbactam Utilization Cost on Patients With Mild and Moderate Corona Virus Disease- 2019: Studi Biaya Penggunaan Antibiotik Levofloxacin Dan Cefoperazone-Sulbactam Pada Pasien Corona Virus Disease-2019 Derajat Ringan Sampai Sedang. Pharmasci 2024, 9 (1), 59-63. https://doi.org/10.53342/pharmasci.v9i1.316.